Dian Xiong
299 Qingyang Road
Wuxi, 214023, China
Wuxi, 214023, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Targeting SHP2 to reverse immune evasion and resistance to anti-PD-1 therapy in non-small cell lung cancer.
Journal: Cell communication and signaling : CCS
Published: July 14, 2025
SPP1 induces idiopathic pulmonary fibrosis and NSCLC progression via the PI3K/Akt/mTOR pathway.
Journal: Respiratory research
Published: May 16, 2024
Clinical outcome of lung transplantation for chronic thromboembolic pulmonary hypertension.
Journal: BMC pulmonary medicine
Published: April 06, 2024
ARC@DPBNPs suppress LPS-induced acute lung injury via inhibiting macrophage pyroptosis and M1 polarization by ERK pathway in mice.
Journal: International immunopharmacology
Published: January 05, 2024
Network pharmacology and molecular docking reveal the mechanisms of curcumin activity against esophageal squamous cell carcinoma.
Journal: Frontiers in pharmacology
Published: August 24, 2023
Arctiin-encapsulated DSPE-PEG bubble-like nanoparticles inhibit alveolar epithelial type 2 cell senescence to alleviate pulmonary fibrosis via the p38/p53/p21 pathway.
Journal: Frontiers in pharmacology
Published: January 10, 2023
The impact of long-term exposure to tacrolimus on chronic kidney disease after lung transplantation: A retrospective analysis from a single transplantation center.
Journal: Transplant immunology
Published: November 01, 2022
Cancer cell-derived exosomal circUSP7 induces CD8+ T cell dysfunction and anti-PD1 resistance by regulating the miR-934/SHP2 axis in NSCLC.
Journal: Molecular cancer
Published: December 29, 2020
Interleukin-8 as a candidate for thymoma identification and recurrence surveillance.
Journal: Nature communications
Published: January 30, 2020
High level of H3K4 tri-methylation modification predicts poor prognosis in esophageal cancer.
Journal: Journal of Cancer
Published: May 18, 2019
Last Updated: 09/26/2026